| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,700 |
3,384 |
$508K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,093 |
2,592 |
$262K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
373 |
292 |
$35K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
759 |
675 |
$34K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,093 |
951 |
$30K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,093 |
951 |
$30K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
637 |
505 |
$27K |
| 80053 |
Comprehensive metabolic panel |
4,790 |
4,013 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
551 |
485 |
$24K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,205 |
1,040 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
212 |
164 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,011 |
4,171 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
353 |
298 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
987 |
838 |
$11K |
| 80306 |
|
1,077 |
964 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
374 |
310 |
$9K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
253 |
202 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
188 |
168 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
76 |
74 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
96 |
84 |
$6K |
| 82607 |
|
557 |
464 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
799 |
695 |
$5K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24 |
24 |
$5K |
| 83880 |
|
277 |
238 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
374 |
287 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
647 |
567 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
43 |
42 |
$3K |
| 87481 |
|
193 |
168 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
192 |
168 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
51 |
44 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
145 |
134 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
2,237 |
1,862 |
$3K |
| 82746 |
|
280 |
236 |
$3K |
| 83605 |
|
465 |
401 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$3K |
| 87088 |
|
425 |
374 |
$2K |
| 84484 |
|
362 |
294 |
$2K |
| 86803 |
|
171 |
148 |
$2K |
| 80061 |
Lipid panel |
184 |
167 |
$2K |
| 81001 |
|
1,297 |
1,114 |
$2K |
| 87634 |
|
16 |
14 |
$842.40 |
| 83690 |
|
279 |
240 |
$723.44 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
79 |
61 |
$716.38 |
| 80081 |
|
12 |
12 |
$688.69 |
| 82728 |
|
96 |
80 |
$669.62 |
| 80055 |
|
14 |
14 |
$543.26 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
44 |
39 |
$515.72 |
| 84439 |
|
62 |
61 |
$455.00 |
| 83735 |
|
117 |
109 |
$419.15 |
| 85730 |
|
91 |
82 |
$314.17 |
| 85027 |
|
286 |
208 |
$251.37 |
| 87430 |
|
28 |
26 |
$237.94 |
| 85610 |
|
116 |
95 |
$231.13 |
| 87510 |
|
17 |
13 |
$216.10 |
| 87660 |
|
17 |
13 |
$216.10 |
| 87480 |
|
17 |
13 |
$212.10 |
| 82950 |
|
42 |
39 |
$189.42 |
| 87807 |
|
20 |
17 |
$179.67 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
154 |
108 |
$154.02 |
| 83655 |
|
13 |
12 |
$141.00 |
| 81025 |
|
29 |
25 |
$92.63 |
| 87081 |
|
13 |
12 |
$88.18 |
| 87040 |
|
22 |
15 |
$82.82 |
| 86592 |
|
13 |
12 |
$56.79 |
| 86850 |
|
14 |
12 |
$25.25 |
| 85018 |
|
26 |
24 |
$20.08 |
| 85014 |
|
26 |
24 |
$20.08 |
| J2704 |
Injection, propofol, 10 mg |
18 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
26 |
12 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17 |
13 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
233 |
39 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
14 |
14 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$0.00 |